T2 Biosystems (TTOO) Competitors $0.35 +0.02 (+4.76%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TTOO vs. POCI, BSGM, IRIX, FEMY, VVOS, CODX, DRIO, ALUR, NRXS, and MBOTShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include Precision Optics (POCI), BioSig Technologies (BSGM), IRIDEX (IRIX), Femasys (FEMY), Vivos Therapeutics (VVOS), Co-Diagnostics (CODX), DarioHealth (DRIO), Allurion Technologies (ALUR), NeurAxis (NRXS), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. Precision Optics BioSig Technologies IRIDEX Femasys Vivos Therapeutics Co-Diagnostics DarioHealth Allurion Technologies NeurAxis Microbot Medical T2 Biosystems (NASDAQ:TTOO) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk, community ranking and analyst recommendations. Which has stronger earnings & valuation, TTOO or POCI? Precision Optics has higher revenue and earnings than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.68M0.96-$50.08MN/AN/APrecision Optics$18.98M1.74-$2.95M-$0.62-8.40 Is TTOO or POCI more profitable? Precision Optics has a net margin of -20.01% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Precision Optics' return on equity.Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% Precision Optics -20.01%-35.51%-21.67% Does the MarketBeat Community believe in TTOO or POCI? T2 Biosystems received 406 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 64.14% of users gave T2 Biosystems an outperform vote while only 0.00% of users gave Precision Optics an outperform vote. CompanyUnderperformOutperformT2 BiosystemsOutperform Votes40664.14% Underperform Votes22735.86% Precision OpticsOutperform VotesNo VotesUnderperform Votes2100.00% Does the media refer more to TTOO or POCI? In the previous week, T2 Biosystems had 7 more articles in the media than Precision Optics. MarketBeat recorded 7 mentions for T2 Biosystems and 0 mentions for Precision Optics. T2 Biosystems' average media sentiment score of 0.49 beat Precision Optics' score of 0.00 indicating that T2 Biosystems is being referred to more favorably in the media. Company Overall Sentiment T2 Biosystems Neutral Precision Optics Neutral Do analysts recommend TTOO or POCI? T2 Biosystems currently has a consensus target price of $5.00, suggesting a potential upside of 1,328.57%. Given T2 Biosystems' stronger consensus rating and higher possible upside, analysts plainly believe T2 Biosystems is more favorable than Precision Optics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Precision Optics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals have more ownership in TTOO or POCI? 23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 0.1% of T2 Biosystems shares are held by company insiders. Comparatively, 16.3% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, TTOO or POCI? T2 Biosystems has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500. SummaryT2 Biosystems beats Precision Optics on 9 of the 15 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.37M$4.33B$5.12B$9.07BDividend YieldN/A41.46%4.91%4.22%P/E RatioN/A25.3791.3417.19Price / Sales0.9645.671,116.63116.80Price / CashN/A43.4642.5837.86Price / Book-0.057.364.794.78Net Income-$50.08M$13.64M$120.07M$225.60M7 Day Performance-4.11%-2.81%-1.90%-1.24%1 Month Performance-17.80%0.55%11.43%3.06%1 Year Performance-92.74%41.80%30.59%16.50% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 Biosystems2.7886 of 5 stars$0.35+4.8%$5.00+1,328.6%-93.4%$7.37M$7.68M0.00180Analyst ForecastPOCIPrecision OpticsN/A$5.00-2.0%N/A-16.2%$31.75M$19.10M0.0080High Trading VolumeBSGMBioSig Technologies1.2184 of 5 stars$1.68+14.3%$2.75+63.7%-69.0%$28.96M$39,000.000.0050IRIXIRIDEX0.3499 of 5 stars$1.71-0.6%$2.00+17.0%-37.2%$28.45M$48.43M-2.57120Analyst ForecastNews CoverageFEMYFemasys2.1386 of 5 stars$1.18-0.8%$10.00+747.5%+23.4%$27.02M$1.26M-1.4730VVOSVivos Therapeutics2.8425 of 5 stars$5.30+15.0%$6.30+18.9%-59.0%$25.65M$13.80M-0.81160Positive NewsGap UpCODXCo-Diagnostics3.8281 of 5 stars$0.80-4.0%$1.50+87.8%-38.1%$25.51M$7.32M-0.60100DRIODarioHealth2.2551 of 5 stars$0.71-3.0%$4.00+463.2%-50.9%$24.22M$23.05M-0.78200News CoveragePositive NewsALURAllurion Technologies2.0405 of 5 stars$0.32-7.2%$2.88+796.2%-89.7%$20.65M$34.75M-0.67501Gap UpNRXSNeurAxisN/A$2.46-0.8%N/A+13.7%$17.17M$2.46M-1.3519Gap DownMBOTMicrobot Medical2.6641 of 5 stars$1.00flat$7.00+600.0%-28.7%$16.93MN/A-1.2520Positive News Related Companies and Tools Related Companies Precision Optics Competitors BioSig Technologies Competitors IRIDEX Competitors Femasys Competitors Vivos Therapeutics Competitors Co-Diagnostics Competitors DarioHealth Competitors Allurion Technologies Competitors NeurAxis Competitors Microbot Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TTOO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
